3,688
edits
No edit summary |
No edit summary |
||
Line 18: | Line 18: | ||
[https://pubmed.ncbi.nlm.nih.gov/12401594/ Pulmonary-to-systemic blood flow ratio effects of sevoflurane, isoflurane, halothane, and fentanyl/midazolam with 100% oxygen in children with congenital heart disease] | [https://pubmed.ncbi.nlm.nih.gov/12401594/ Pulmonary-to-systemic blood flow ratio effects of sevoflurane, isoflurane, halothane, and fentanyl/midazolam with 100% oxygen in children with congenital heart disease] | ||
[https://pubmed.ncbi.nlm.nih.gov/35483048/ End-tidal Anesthetic Concentration: Monitoring, Interpretation, and Clinical Application.] | |||
[https://www.apsf.org/article/off-label-low-flow-sevoflurane-regulatory-red-herring-or-liability-landmine/ Off-Label Low-Flow Sevoflurane: Regulatory Red Herring or Liability Landmine?] | [https://www.apsf.org/article/off-label-low-flow-sevoflurane-regulatory-red-herring-or-liability-landmine/ Off-Label Low-Flow Sevoflurane: Regulatory Red Herring or Liability Landmine?] |